Clear market notes built around the JSE, the rand, and what matters locally.

2026-10-04 21:15 • The Motley Fool Mixed Axe Cap view: Selective

Both Pfizer and Novo Nordisk face significant dividend safety concerns despite high yields. Novo Nordisk (4.7% yield) leads in GLP-1 drugs but has lost market share to Eli Lilly and lacks portfolio diversity, while Pfizer (6% yield) faces patent expirations and R&D challenges. However, Pfizer's broader product portfolio and acquisition strategy make it the relatively safer choice for dividend investors, despite both stocks carrying material risk.

Axe note: Despite higher yield, Novo Nordisk’s dividend safety is shakier compared to Pfizer’s broader portfolio and acquisition edge.

2026-10-04 20:17 • The Motley Fool Positive Axe Cap view: Selective

Berkshire Hathaway is positioned as an attractive stock to buy ahead of a potential market crash due to its diversified business model, strong insurance division generating $177.5 billion in float, and substantial liquidity of $359.2 billion in cash and equivalents. The company's recent multi-billion dollar share buybacks suggest management believes the stock is undervalued. Under new CEO Greg Abel and with Buffett's investment philosophy embedded in company culture, Berkshire Hathaway is recommended as both a crash-resistant investment and a long-term holding.

Axe note: Berkshire Hathaway’s cash-rich, diversified model makes it a standout if global markets tumble, with clear lessons for JSE watchers.

2026-10-04 19:05 • The Motley Fool Neutral Axe Cap view: Selective

Netflix has been an exceptional long-term performer, turning $1,000 into $43,000 over 15 years. However, the company's growth is slowing with Q2 revenue up only 13.4% year-over-year. While valuation metrics appear reasonable compared to historical averages, the mature streaming market with intense competition from Amazon Prime Video, Apple TV, and YouTube makes Netflix not particularly compelling at current levels. The author suggests buying a little could work long-term, but better opportunities exist elsewhere.

Axe note: Netflix’s streak of outsized growth is waning, making the stock less attractive amid streaming competition and slowing revenue.